Riabni 100 mg/10mL
rituximab-arrx · INJECTION, SOLUTION · Amgen, Inc
No Recall History
Plain English
Riabni is a injection, solution containing rituximab-arrx at 100 mg/10mL, taken intravenous. Manufactured by Amgen, Inc.
Key Facts
- Brand Name
- Riabni
- Generic Name
- rituximab-arrx
- NDC Code (Product)
55513-224- Manufacturer
- Amgen, Inc
- Strength
- 100 mg/10mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761140
- Drug Class
- CD20-directed Cytolytic Antibody [EPC]
- Marketing Start
- 01/06/2021
Recall History
No Recall HistoryFrequently Asked Questions
What is Riabni used for?
Riabni contains rituximab-arrx. It is a injection, solution taken intravenous. Consult your doctor for specific uses.
Is Riabni a controlled substance?
Riabni is not classified as a controlled substance by the DEA.
What is the generic name for Riabni?
The generic name for Riabni is rituximab-arrx. There are no other listed brand versions of rituximab-arrx.
What is the NDC code for Riabni 100 mg/10mL?
The NDC (National Drug Code) for Riabni 100 mg/10mL is 55513-224, listed by Amgen, Inc.
Other Riabni Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)